Nasdaq · Healthcare
Talkspace, Inc. (TALK)
As-reported financials and recent SEC filings for Talkspace, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$228.9M
Net income
$7.8M
Net margin
3.4%
Diluted EPS
$0.04
ROE
6.7%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $228.9M | $187.6M | $150.0M | $119.6M | $113.7M |
| Gross profit | — | $85.8M | $74.4M | $60.3M | $66.8M |
| Operating income | $3.2M | $-4.5M | $-23.2M | $-83.2M | $-93.9M |
| Net income | $7.8M | $1.1M | $-19.2M | $-79.7M | $-62.7M |
| Diluted EPS | $0.04 | $0.01 | $-0.12 | $-0.51 | $-0.72 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
25-NSE2026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →Largest Healthcare peers
Go deeper on TALK
Search Talkspace, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.